Topic: DCGI
India’s first intra-nasal Corona vaccine: GK & Current Affairs Facts
The country’s first intranasal COVID vaccine iNCOVACC by Bharat Biotech has recently received DCGI approval for primary immunization against the infection for people above the age of 18...
2DG- DRDO’s Anti-Covid Drug
On May 17, 2021, the DRDO released the first batch of 2-DG drugs. The 2-DG was developed by the Defence Research Development Organisation for Emergency Use. 2-DG is...
Indian Company Zydus Cadila Starts Clinical Trial for COVID 19 Vaccine
The Indian pharmaceutical behemoth, Zydus Cadila, has started the Phase I, II clinical trials for its COVID 19 vaccine. The pharma giant had received approval from the Drug...
First indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine Approved by DCGI
The first-ever completely home-grown Pneumococcal Polysaccharide Conjugate Vaccine has been approved by the Drug Controller General of India. The vaccine has been developed by Serum Institute of India,...
DCGI allows use of “Itolizumab” for moderate to severe COVID-19 cases
On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal...
CSIR: Clinical Trial of “Sepsivac” drug on critically ill COVID-19 patients
On April 22, 2020, the Council of Scientific and Industrial Research announced that it is to go for clinical trials on critically ill COVID-19 patients. Background The Drugs...
DCGI approves COVID-19 drug to reduce mortality rate
On April 20, 2020, the Drugs Controller General of India (DCGI) approved trial of a drug to reduce mortality rate of COVID-19 patients. Highlights The COVID-19 drug that...
Drugs and Clinical Trials Rules, 2019
The Union Ministry for Health and Family Welfare has notified the Drugs and Clinical Trials Rules, 2019 with an aim to promote clinical research in the country. Features...
